Charles A. Sammons Cancer Center — Dallas, Texas

Charles A. Sammons Cancer Center is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Charles A. Sammons Cancer Center has participated in 9 clinical trials.

Therapeutic areas: Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin.

Sponsors: Seagen Inc., Aventis Pharmaceuticals, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charles A. Sammons Cancer Center?

Charles A. Sammons Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charles A. Sammons Cancer Center conducted?

Charles A. Sammons Cancer Center has 9 clinical trials on record. Their work covers Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin.

Is Charles A. Sammons Cancer Center accredited by Crixeo Health?

Yes — Charles A. Sammons Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Charles A. Sammons Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.